IL150100A0 - Pharmaceutical compositions containing fused cyclic compounds - Google Patents

Pharmaceutical compositions containing fused cyclic compounds

Info

Publication number
IL150100A0
IL150100A0 IL15010001A IL15010001A IL150100A0 IL 150100 A0 IL150100 A0 IL 150100A0 IL 15010001 A IL15010001 A IL 15010001A IL 15010001 A IL15010001 A IL 15010001A IL 150100 A0 IL150100 A0 IL 150100A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
cyclic compounds
containing fused
fused cyclic
Prior art date
Application number
IL15010001A
Original Assignee
Morphochem Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphochem Ag filed Critical Morphochem Ag
Publication of IL150100A0 publication Critical patent/IL150100A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention relates to the use of a compound of formula (I), where U-V-W (R1)-X(R2)-Y-Z = RHN-C=CR1-CR2=C-OH, HO-C=CR1-CR2=C-OH or O=C-CR1=CR2-C=O; A = N or CH; R = H, C1-C6 alkyl or benzyl; R1 = H or methyl and R2 = H or a group of formula (II) or (III), for treatment or prophylaxis of Hepatitis C.
IL15010001A 2000-01-17 2001-01-15 Pharmaceutical compositions containing fused cyclic compounds IL150100A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10001729A DE10001729A1 (en) 2000-01-17 2000-01-17 Treatment or prevention of hepatitis C infection by administration of certain bicyclic compounds, e.g. 2-methyl-1,4-naphthoquinone
PCT/EP2001/000390 WO2001052824A2 (en) 2000-01-17 2001-01-15 Use of particular compounds for prophylaxis and treatment of hepatitis c

Publications (1)

Publication Number Publication Date
IL150100A0 true IL150100A0 (en) 2002-12-01

Family

ID=7627769

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15010001A IL150100A0 (en) 2000-01-17 2001-01-15 Pharmaceutical compositions containing fused cyclic compounds

Country Status (8)

Country Link
EP (1) EP1248603B1 (en)
JP (1) JP2003520225A (en)
AT (1) ATE279182T1 (en)
AU (1) AU3730201A (en)
CA (1) CA2393694A1 (en)
DE (2) DE10001729A1 (en)
IL (1) IL150100A0 (en)
WO (1) WO2001052824A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031011A1 (en) * 2003-05-20 2004-11-21 Vanetta S P A BIOCIDAL COMPOUNDS FOR WATER TREATMENT.
CN1946385A (en) * 2004-02-20 2007-04-11 罗伯特·F·霍夫曼 Use of targeted oxidative therapeutic formulation in treatment of viral diseases
WO2005084649A1 (en) * 2004-03-04 2005-09-15 Takeda Pharmaceutical Company Limited Stable capsule preparation
GB0806794D0 (en) * 2008-04-15 2008-05-14 Ludwig Inst Cancer Res Therapeutic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502008A1 (en) * 1981-03-19 1982-09-24 Chekroun Mehir Antitumour compositions - containing gum ammoniac and vitamin=K
DE3431236A1 (en) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen USE OF 1,4-NAPHTHOQUINONE DERIVATIVES IN LOW CONCENTRATIONS FOR IMMUNE STIMULATION
DK196688A (en) * 1987-04-28 1988-10-29 Fujisawa Pharmaceutical Co BICYCLIC RELATIONS AND PROCEDURES FOR PRODUCING THEREOF
US6080791A (en) * 1992-07-24 2000-06-27 Seres Laboratories, Inc. Method of treating a viral condition by inhibiting membrane fusion
AU5157998A (en) * 1996-11-01 1998-05-29 Thomas Najarian Methods and compositions for treatment of hepatitis c infection

Also Published As

Publication number Publication date
DE10001729A1 (en) 2001-07-26
EP1248603A2 (en) 2002-10-16
WO2001052824A3 (en) 2002-03-07
ATE279182T1 (en) 2004-10-15
AU3730201A (en) 2001-07-31
DE50104100D1 (en) 2004-11-18
CA2393694A1 (en) 2001-07-26
JP2003520225A (en) 2003-07-02
WO2001052824A2 (en) 2001-07-26
EP1248603B1 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
NL350075I2 (en)
IL150650A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
MXPA04001323A (en) Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use.
ID17851A (en) HETEROSICLIC COMPOUNDS, PRODUCTION AND USAGE
EP1254659A4 (en) Stable emulsion compositions
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
MXPA02012033A (en) 2-aminocarbonyl-9h-purine derivatives.
HK1087022A1 (en) Dpp-iv inhibitors
AP1541A (en) New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors.
EP1775289A4 (en) Novel imidazolidine derivatives
MY126917A (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
ZA9610418B (en) Phenylimidazolidines containing in particular a nitrooxy or carbonyloxy radical, preparation process and intermediates, use as medicaments, new uses and pharmaceutical compositions.
PT849269E (en) VINYL-PYRROLIDINE CEFALOSPORINES WITH BASIC SUBSTITUENTS
MXPA03000547A (en) Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder.
BG100884A (en) Benzamide derivative, compositions containing said derivative and use thereof
DE60114640D1 (en) Antithrombosemittel
IL150100A0 (en) Pharmaceutical compositions containing fused cyclic compounds
MY129094A (en) Condensed polycyclic compounds
AP1396A (en) 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives.
MY136065A (en) Prodrugs to nmda receptor ligands
MY133207A (en) Substituted benzolactam compaunds
EA200200682A1 (en) NEW COMPOUNDS OF N-BENZYLPIPERASINE, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP1057829A4 (en) Novel compounds and pharmaceutical compositions containing the same
DK1312608T3 (en) Discodermolide analogs and their pharmaceutical use